Ledger.Open graph →
SEC Form D · Amendment · filed December 27, 2017

Processa Pharmaceuticals, Inc

Offering
$2.6M
Sold
$2.6M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
HANOVER, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Justin York · Hanover, MDDirectorDavid Young · Hanover, MDExec · DirectorVirgil W. Thompson · Hanover, MDDirectorPatrick Lin · Hanover, MDExec · DirectorEagle Point Global Management GP, LLC · Seattle, WADirectorJeffrey Harrell · San Jose, CADirectorEagle Point Global Management, LP · Seattle, WAExec · DirectorMark F. Van Coeverden De Groot · Toronto, Ontario, CanadaExec · DirectorJohn Schanz · Villanova, PADirectorBrian Cassidy · New York, NYExec · DirectorStephen Tiller · New York, NYDirectorGregory J. Smith · New York, NYExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗